Evidence map›Paper›PMID 33657859›Full record

ArticleStroke2021

Stroke Risk Factor Status and Use of Stroke Prevention Medications Among Hispanic/Latino Adults in HCHS/SOL.

Fang Bai, Jingsong Chen, Dilip Pandey, Ramon Durazo-Arvizu, Gregory A Talavera, Matthew A Allison, Krista M Perreira, Neil Schneiderman, Melanie W Sutherland, Jianwen Cai and 2 more

Registry-linked trialOpen access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Stroke, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02060344 (Hispanic Community Health Study / Study of Latinos), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02060344 active not recruitingnot on this map

Hispanic Community Health Study / Study of Latinos (HCHS/SOL)

TypeobservationalSponsorNational Heart, Lung, and Blood Institute (NHLBI)Ran2006 to 2032Enrolled16,400ConditionsCardiovascular Disease
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Stroke prevention and therapy awareness in a large sample of high school students: results of an educational campaign in the Northern-Western Italy.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  3. Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Fang BaiDepartment of Neurology and Rehabilitation (F.B., D.P., F.D.T.), University of Illinois at Chicago.
Jingsong ChenInstitute for Minority Health Research (J.C., R.D.-A., M.L.D.), University of Illinois at Chicago.
Dilip PandeyDepartment of Neurology and Rehabilitation (F.B., D.P., F.D.T.), University of Illinois at Chicago.
Ramon Durazo-ArvizuInstitute for Minority Health Research (J.C., R.D.-A., M.L.D.), University of Illinois at Chicago.
Gregory A TalaveraGraduate School of Public Health, San Diego State University, CA (G.A.T.).
Matthew A AllisonDepartment of Family and Preventive Medicine, University of California, San Diego, La Jolla (M.A.A.).
Krista M PerreiraCollaborative Studies Coordinating Center, University of North Carolina at Chapel Hill (K.M.P., J.C.).
Neil SchneidermanDepartment of Psychology, Behavioral Medicine Research Center, University of Miami, FL (N.S.).
Melanie W SutherlandDepartment of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia (M.W.S.).
Jianwen CaiCollaborative Studies Coordinating Center, University of North Carolina at Chapel Hill (K.M.P., J.C.).
Martha L DaviglusInstitute for Minority Health Research (J.C., R.D.-A., M.L.D.), University of Illinois at Chicago.
Fernando D TestaiDepartment of Neurology and Rehabilitation (F.B., D.P., F.D.T.), University of Illinois at Chicago.
University of Illinois Chicago · USUniversity of North Carolina at Chapel Hill · USSan Diego State University · USSchneider Electric (France) · FRUniversity of California San Diego · USUniversity of South Carolina · US

Funding

Pilot Program CoreP30ES027792 · NIEHS · UNIVERSITY OF CHICAGO · PI Gokhan M. Mutlu, Gail S Prins · 2017 to 2026
$13.6M
New York Regional Center for Diabetes Translation Research - Translational Intervention Methodology CoreP30DK111022 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JEFFREY GONZALEZ · 2016 to 2026
$7.8M
Thalassemia Clinical Research Network, CanadaU01HL065233 · NHLBI · UNIVERSITY HEALTH NETWORK · PI OLIVIERI, NANCY F · 2000 to 2009
$2.6M
GENETIC ARCHITECTURE OF PLASMA T-PA AND PAI-1R01HL065234 · NHLBI · VANDERBILT UNIVERSITY · PI MOORE, JASON H. · 2000 to 2004
$1.7M
HISPANIC COMMUNITY HEALTH STUDY-268065233N01HC065233 · HC · COORDINATING CENTER · PI CHAMBLESS, LLOYD E · 2006 to 2006
–
NHLBI NIH HHS N01 HC065233NHLBI NIH HHS N01 HC065234NHLBI NIH HHS N01 HC065235NHLBI NIH HHS N01 HC065236NHLBI NIH HHS N01 HC065237NIDDK NIH HHS P30 DK111022NIEHS NIH HHS P30 ES027792
6 · The paper itself

Abstract

background and purposeWe investigated the prevalence, awareness, and control of vascular risk factors (VRFs) and the use of antithrombotic and statin agents in HCHS (Hispanic Community Health Study)/SOL (Study of Latinos) participants with self-reported history of stroke or transient ischemic attack.

methodsSociodemographic characteristics, medications, and prevalence of different VRFs were recorded. VRF diagnoses and goals were based on the recommendations of professional organizations. Factors associated with optimal VRF control and use of antithrombotic and statin agents were investigated using multivariate logistic regression.

resultsThe analysis included 404 participants (39% men). The prevalences of hypertension, dyslipidemia, and diabetes were 59%, 65%, and 39%, respectively. Among those who met the diagnostic criteria for these diagnoses, the frequencies of awareness were 90%, 75%, and 83%, respectively. In participants who were aware of their VRFs, the prevalences of controlled hypertension, dyslipidemia, and diabetes were 46%, 32%, and 54%. Approximately 46% of the participants were on antithrombotics, 39% on statins, and 26% on both. Only 38% of those with atrial fibrillation received anticoagulation. In multivariate analyses adjusted for baseline sociodemographic characteristics, older age was associated with uncontrolled hypertension and diabetes. Residing in the United States for ≥10 years and born in the United States were associated with uncontrolled diabetes, female sex with uncontrolled dyslipidemia, and lack of health insurance with decreased use of statins and hyperlipidemia.

conclusionsHispanic/Latino adults in the United States have high prevalence and awareness of VRFs but low adherence to secondary stroke prevention strategies. Older adults, women, and uninsured people are vulnerable groups that may benefit from targeted interventions. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02060344.

Indexed as

Secondary PreventionAgedCardiovascular DiseasesCohort StudiesDrug MonitoringFemaleFibrinolytic AgentsHispanic or LatinoHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMiddle AgedPrevalenceRisk FactorsStrokeUnited StatesFibrinolytic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitorsethnic groupsgoalsrisk factorssecondary preventionstroke

Identifiers

PMID33657859
PMCPMC7988300
OpenAlexW3134738542

What OpenQuestion holds

Texttitle and abstract
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.